KLK3 and posterior cortical atrophy: Through our research on low risk and intermediate risk PCa patients, we could find that although the short-term oncologic and functional outcomes of FLA were excellent, RT was still significantly better than FLA in long-term survival benefits, especially for patients with T stage T1, PSA < 4 ng/mL, and GS 4 + 3.